Patent
Conjugates and methods of use thereof for selective delivery of immune-modulatory agents
Reads0
Chats0
TLDR
In this article, the compositions of conjugates comprising immune-modulatory agents are also provided, including methods for treating disorders, such as cancer and fibrosis, as well as methods of preparation and use of the conjugate.Abstract:
Various compositions are disclosed. The compositions of conjugates comprising immune-modulatory agents are also provided. Additionally provided are the methods of preparation and use of the conjugates. This includes methods for treating disorders, such as cancer and fibrosis.read more
Citations
More filters
Patent
Antibody adjuvant conjugates
Michael N. Alonso,Edgar G. Engleman,Shelley Erin Ackerman,Justin A. Kenkel,Arthur Lee,David Y. Jackson +5 more
TL;DR: In this paper, an immunoconjugate comprising an antibody construct which includes an antigen binding domain and an Fc domain, an adjuvant moiety, and a linker was described.
Patent
Anti-mesothelin antibodies and immunoconjugates thereof
TL;DR: In this article, anti-mesothelin antibodies and conjugates comprising such antibodies are disclosed as well as the use of such antibodies in the treatment of disease, such as cancer.
Patent
Aminoquinoline compounds, immunoconjugates, and uses thereof
TL;DR: In this article, the authors provide immunoconjugates of Formula (I) comprising an antibody linked by conjugation to one or more aminoquinoline derivatives, which are suitable substrates for the formation of the immunocorjugates through a linker or linking moiety.
Patent
Tgfbetar1 inhibitor-asgr antibody conjugates and uses thereof
Peter Robert Baum,Robert F. Dubose,Valerie Odegard,Philip Tan,Peter A. Thompson,Sean W. Smith,Brenda L. Stevens +6 more
TL;DR: In this article, various conjugates and compositions thereof are disclosed for use in the treatment of a liver disease, such as liver cancer and liver fibrosis, and the methods of preparation of the conjugate and composition thereof are provided.
Patent
Formulations of Benzazepine Conjugates and Uses Thereof
TL;DR: In this article, aqueous formulations comprising conjugates that comprise a compound comprising benzazepine or a benzazetine-like structure conjugated to a polypeptide are provided.
References
More filters
Patent
Silver halide color photographic light-sensitive material.
Keisuke Shiba,Ogawa Tadashi +1 more
TL;DR: In this article, a silver halide color photographic light sensitive material with a compound represented by the following Formula [I] in at least one of the photographic component layers, a compound representing by Formula [II] and Formula [III] in the photographic components, and a compound representation represented by formula [IV] and formula [V] in each photographic component layer.
Patent
Optimized Fc Variants
Gregory Alan Lazar,Wei Dang,John R. Desjarlais,Sher Bahadur Karki,Omid Vafa,Robert J. Hayes,Jost Vielmetter +6 more
TL;DR: In this paper, the present invention relates to Fc variants having decreased affinity for FcγRIIb, methods for their generation, Fc polypeptides comprising optimized fc variants, and methods for using optimized f c variants.
Patent
FC variants with altered binding to FCRN
Aaron Chamberlain,John R. Desjarlais,Sher Bahadur Karki,Greogory Alan Lazar,Jost Vielmetter,Sean Yoder +5 more
TL;DR: In this paper, the present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes, particularly related to optimized IGs.
Patent
Method of using deuterated calcium channel blockers
TL;DR: In this article, a method of enhancing the efficiency and increasing the duration of action of drugs (e.g., dihydropyridines and anti-bacterials) and particularly of nifedipine and penicillins wherein one or more hydrogen atoms are deuterated was presented.
Patent
Modulators of toll-like receptors
Manoj C. Desai,Randall L. Halcomb,Paul Hrvatin,Hui Hon Chung,Ryan Mcfadden,Paul A. Roethle,Yang Hong +6 more
TL;DR: In this paper, the present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds and therapeutic methods for TLRs.